NewLink Genetics Corp (NASDAQ:NLNK)

48.93
Delayed Data
As of Mar 26
 +1.57 / +3.32%
Today’s Change
17.32
Today|||52-Week Range
57.47
+23.09%
Year-to-Date

Today’s Trading

Previous close47.36
Today’s open47.09
Day’s range44.21 - 49.82
Volume703,684
Average volume (3 months)504,881
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio14.8
Price/Sales6.41
Price/Book6.50

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...+0.01+0.01%
LGNDLigand Pharmaceutica...-0.40-0.57%
ZIOPZIOPHARM Oncology In...+0.06+0.54%
ACORAcorda Therapeutics ...-0.69-2.05%
Data as of 4:02pm ET, 03/26/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account